Page last updated: 2024-11-06
7-bromobenzanthracene
7-Bromobenzanthracene is a polycyclic aromatic hydrocarbon (PAH) that has been studied for its carcinogenic properties. It is a potent mutagen and has been shown to induce tumors in laboratory animals. The compound has been found in the environment, including in air, soil, and water. Its presence in the environment is often linked to incomplete combustion processes, such as those that occur in the burning of fossil fuels and the production of coal tar. Its synthesis involves bromination of benzanthracene in the presence of a catalyst, such as iron bromide. Research on 7-bromobenzanthracene is important because it helps to understand the mechanisms of carcinogenesis and to develop strategies for preventing and treating cancer. The compound has been used in the development of new anticancer drugs. It is also used in the development of new methods for the detection of carcinogenic compounds.'
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 72849 |
| SCHEMBL ID | 2787069 |
| MeSH ID | M0116832 |
Synonyms (31)
| Synonym |
|---|
| nsc-30995 |
| benz[a]anthracene, 7-bromo- |
| nsc30995 |
| 32795-84-9 |
| brn 2560467 |
| 10-brom-1,2-benzanthracen [german] |
| benz(a)anthracene, 7-bromo- |
| 7-bromobenzanthracene |
| ccris 3882 |
| 7-bromobenz(a)anthracene |
| nsc 30995 |
| 10-bromo-1,2-benzanthracene |
| 7-bromo-benz[a]anthracene |
| 7-bromobenzo[a]anthracene |
| B1603 |
| 7-bromobenz[a]anthracene |
| AKOS024341191 |
| unii-y8v4q1j7l7 |
| 10-brom-1,2-benzanthracen |
| y8v4q1j7l7 , |
| FT-0639053 |
| LGRNWCDRODWMOH-UHFFFAOYSA-N |
| SCHEMBL2787069 |
| 7-bromobenzo(a)anthracene |
| j35.512g , |
| 7-bromotetraphene |
| DTXSID70186461 |
| mfcd00029016 |
| 7-bromo-benzanthracene |
| Q27294384 |
| T70782 |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.87 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.66 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |